Thomas Jefferson University

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Hoffman-Censits, Jean
One or more keywords matched the following items that are connected to Hoffman-Censits, Jean
Item TypeName
Concept Administration, Intravesical
Concept Aged
Concept Aged, 80 and over
Concept Analysis of Variance
Concept Antibodies, Monoclonal
Concept Antineoplastic Combined Chemotherapy Protocols
Concept Attitude of Health Personnel
Concept BCG Vaccine
Concept Biopsy
Concept Combined Modality Therapy
Concept Drug Eruptions
Concept Humans
Concept Middle Aged
Concept Obesity
Concept Prospective Studies
Concept Retrospective Studies
Concept Biomarkers, Tumor
Concept United States
Concept Antigens, Differentiation, Myelomonocytic
Concept Cystectomy
Concept Antigens, CD
Concept Chemotherapy, Adjuvant
Concept Prostate-Specific Antigen
Concept Th2 Cells
Concept Radiotherapy, Adjuvant
Concept Immunoconjugates
Concept Radiotherapy, Conformal
Concept Neoadjuvant Therapy
Concept Radiotherapy, Intensity-Modulated
Concept Th17 Cells
Concept B7-H1 Antigen
Concept Antibodies, Monoclonal, Humanized
Academic Article Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience.
Academic Article A wealth of new options: a case presentation of the management of castration-recurrent prostate cancer.
Academic Article Enzalutamide: a novel antiandrogen for patients with castrate-resistant prostate cancer.
Academic Article Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: A report from the Bladder Cancer Advocacy Network Clinical Trials Working Group.
Academic Article Identification of distinct Basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
Academic Article Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity.
Academic Article Perioperative and Maintenance Therapy After First-Line Therapy as Paradigms for Drug Discovery in Urothelial Carcinoma.
Academic Article Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Academic Article Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma.
Academic Article A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone.
Academic Article Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Academic Article Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature.
Academic Article Recent developments in the treatment of advanced bladder cancer.
Academic Article First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy.
Academic Article Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.
Academic Article Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations.
Academic Article Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.
Academic Article Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).
Academic Article Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery for Patients with High Grade Upper Tract Urothelial Carcinoma.
Concept Poly(ADP-ribose) Polymerase Inhibitors
Academic Article Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile.
Academic Article Reply by Authors.
Academic Article Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Academic Article Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
Academic Article Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
Academic Article Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1-3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3-altered Advanced/Metastatic Urothelial Carcinoma.
Academic Article Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience.
Academic Article Identification of a synthetic lethal relationship between nucleotide excision repair (NER) deficiency and irofulven sensitivity in urothelial cancer.
Academic Article Imaging urothelial bladder cancer: A VPAC PET targeted approach.
Academic Article New and topics: enfortumab vedotin mechanisms of response and resistance in urothelial cancer - What do we understand so far?
Academic Article Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and Survival.
Academic Article Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma.
Academic Article Molecular subtypes of upper tract urothelial cancer: Setting the stage for precision therapy.
Academic Article Penile sarcomatoid urothelial carcinoma: A case report.
Academic Article A Molecular Inquiry into the Role of Antibody-Drug Conjugates in Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer.
Academic Article Residual CIS after neoadjuvant chemotherapy and radical cystectomy for muscle invasive bladder cancer: Implications for neoadjuvant trials.
Academic Article Targeted Treatment of Locally Advanced and Metastatic Urothelial Cancer: Enfortumab Vedotin in Context.
Academic Article Enfortumab Vedotin-related Cutaneous Toxicity and Radiographic Response in Patients with Urothelial Cancer: A Single-center Experience and Review of the Literature.
Academic Article Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline.
Academic Article Enhancing bladder cancer care through the multidisciplinary clinic approach.
Academic Article Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations.
Academic Article Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.05.023.
Academic Article Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Academic Article Enfortumab vedotin-related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experience.
Academic Article Racial Differences in Cutaneous Events Among Patients Receiving Enfortumab Vedotin.
Academic Article Frontline immune checkpoint inhibitors in patients = 90 years with advanced urothelial cancer: a single center experience.
Academic Article Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis.
Academic Article The biologic landscape and therapeutic implications of upper tract urothelial cancer.
Academic Article Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.
Academic Article Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures.
Academic Article Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).
Academic Article The Role of Antibody-Drug Conjugates in Urothelial Cancer: A Review of Recent Advances in the Treatment of Locally Advanced and Metastatic Urothelial Cancer.
Academic Article Sarcomatoid areas of urothelial carcinoma are enriched for CD163-positive antigen-presenting cells.
Academic Article Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade.
Search Criteria
  • Poly ADP Ribose Polymerase
  • 1